Bruce McCreedy

Dr. McCreedy has more than 25 years of experience in the development of small molecule and biologic drug products. He has served as the Senior Vice President of cell therapy at Precision Biosciences since September 2015. Prior to his position at Precision Biosciences, Dr. McCreedy was the Executive Vice President of Research and Development and Chief Development Officer of Neximmune, and the managing partner of PharmaNav. Additionally, Dr. McCreedy served as Vice President of Strategic and Clinical Development at Metabolon and as President, Chief Executive Officer, and Director at Fulcrum Pharma Developments. Dr. McCreedy also served in various roles at Triangle Pharmaceuticals, Therapyedge, Laboratory Corporation of America Holdings, and Roche Biomedical Laboratories.

Dr. McCreedy earned a B.S. in Medical Microbiology from Wake Forest University and a Ph.D. in Microbiology and Immunology from Wake Forest University School of Medicine.